The Effect of Acorus Gramineus on the Bioavailabilities and Brain Concentrations of Ginsenosides Rg1, Re and Rb1 After Oral Administration of Kai-Xin-San Preparations in Rats
Overview
Affiliations
Aim Of The Study: To investigate the effect of Acorus gramineus (AG), a supposed 'delivering servant' according to traditional Chinese medicine principles governing multi-herb formula preparation and formulation, on facilitating the uptake of ginsenosides Rg1, Re and Rb1 to the brain after oral administration of Kai-Xin-San (KXS) preparations.
Materials And Methods: Ginseng extracts or KXS with or without AG were administered to rats for pharmacokinetic study and mice for behaviour tests at a dose of 3 g ginseng per kg. The concentrations of ginsenosides in plasma and brain were determined by an LC-MS/MS method, whilst the effects of preparations on spatial learning were evaluated using the Morris water maze test.
Results: KXS in the presence of AG tended to significantly reverse the learning impairment induced by scopolamine. The presence of AG in the KXS formula led to increases in the initial absorption rate and extent of Rg1 and Re in terms of Cmax1 and AUC(0-3h) compared to KXS without AG. Although KXS were found to increase the bioavailabilities and brain concentrations of ginsenosides relative to ginseng extract, the brain-to-plasma AUC(0-12h) ratios appeared not to be affected.
Conclusions: The results suggested that the presence of AG in the KXS formula promoted the initial absorption of ginsenosides Rg1 and Re in the gastrointestinal tract, but unlikely affected the brain-to-plasma AUC ratios.
Chen L, Jiang L, Shi X, Yang J, Wang R, Li W Front Pharmacol. 2024; 15:1338024.
PMID: 38362144 PMC: 10867185. DOI: 10.3389/fphar.2024.1338024.
Hu Q, Hong H, Zhang Z, Feng H, Luo T, Li J J Ginseng Res. 2023; 47(6):694-705.
PMID: 38107396 PMC: 10721471. DOI: 10.1016/j.jgr.2023.07.005.
Zhou Z, An R, You L, Liang K, Wang X Medicine (Baltimore). 2023; 102(35):e34891.
PMID: 37657053 PMC: 10476818. DOI: 10.1097/MD.0000000000034891.
Ginsenoside and Its Therapeutic Potential for Cognitive Impairment.
Feng H, Xue M, Deng H, Cheng S, Hu Y, Zhou C Biomolecules. 2022; 12(9).
PMID: 36139149 PMC: 9496100. DOI: 10.3390/biom12091310.
Recent advances and effective strategies in the discovery and applications of natural products.
Xie J, Zhang A, Sun H, Yan G, Wang X RSC Adv. 2022; 8(2):812-824.
PMID: 35538992 PMC: 9077099. DOI: 10.1039/c7ra09475b.